Editorial: Proglucagon-Derived Peptides

Front Endocrinol (Lausanne). 2021 Nov 11:12:776871. doi: 10.3389/fendo.2021.776871. eCollection 2021.

Peter R Flatt¹, Filip K Knop^{2

3

4

5}, Andrei I Tarasov¹

¹ School Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, United Kingdom.
² Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
³ Steno Diabetes Center Copenhagen, Gentofte, Denmark.
⁴ Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Novo Nordisk Foundation Center for Basic Metabolic Research Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

No abstract available

Keywords: L-cell; alpha-cell; diabetes; intestinal function; metabolism; obesity; proglucagon-derived peptides; therapeutics.

Publication types